IFP Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

IFP Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,500	Closed	-$31K	–	4314
2016 Q4	$31K	Sell	2,500 -80,470	-97%	-$969K	﹤0.01%	2193
2016 Q3	$1.14M	Buy	82,970 +29,000	+54%	+$291K	0.06%	329
2016 Q2	$399K	Buy	+53,970	New	+$405K	0.02%	639
2016 Q1	–	Sell	-3,300	Closed	-$21K	–	4113
2015 Q4	$21K	Buy	+3,300	New	+$21.7K	﹤0.01%	2150

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

IFP Advisors's ARIA Position: Q1 2017 in Review

IFP Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 2,500 shares — an estimated $31K sold.

IFP Advisors first reported a position in ARIA in Q4 2015 and held it in 4 quarters. The position peaked at $1.14M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

IFP Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
IFP Advisors sold 2,500 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $31K.
IFP Advisors first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 4 quarters.
IFP Advisors's Ariad Pharmaceuticals Inc position peaked at $1.14M in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on IFP Advisors's 13F filing for Q1 2017, filed 26 Apr 2017.